IFN-β induces the proliferation of CD4 +CD25 +Foxp3 + regulatory T cells through upregulation of GITRL on dendritic cells in the treatment of multiple sclerosis

Journal of Neuroimmunology

Volumn 242, Issue 1-2, 2012, Pages 39-46

  Chen, Meiyue ^a   Chen, Guangjie ^b   Deng, Shaohua ^b   Liu, Xin ^a   Hutton, George J ^a   Hong, Jian ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Dendritic cells; Glucocorticoid induced tumor necrosis factor receptor; Interferon beta; Multiple sclerosis; Regulatory T cells

Indexed keywords

BETA INTERFERON; BETA INTERFERON RECEPTOR; BETA1A INTERFERON; CD14 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR LIGAND; INTERFERON BETA SERINE; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ CD25+ FOXP3+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; UPREGULATION;

ADULT; AGED; ANIMALS; CELLS, CULTURED; CLONAL ANERGY; CTLA-4 ANTIGEN; DENDRITIC CELLS; DOWN-REGULATION; FEMALE; GLUCOCORTICOID-INDUCED TNFR-RELATED PROTEIN; HUMANS; INTERFERON-BETA; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; T-LYMPHOCYTES, REGULATORY; UP-REGULATION;

EID: 84856805188     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2011.10.014     Document Type: Article

References (30)

1. Axtell R.C., de Jong B.A., Boniface K., van der Voort L.F., Bhat R., De Sarno P., Naves R., Han M., Zhong F., Castellanos J.G., Mair R., Christakos A., Kolkowitz I., Katz L., Killestein J., Polman C.H., de Waal Malefyt R., Steinman L., Raman C. T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis. Nat. Med. 2010, 16:406-412.
2. Beyersdorf N., Hanke T., Kerkau T., Hunig T. Superagonistic anti-CD28 antibodies: potent activators of regulatory T cells for the therapy of autoimmune diseases. Ann. Rheum. Dis. 2005, 64(Suppl. 4):iv91-iv95.
3. Boz C., Ozmenoglu M., Velioglu S., Kilinc K., Orem A., Alioglu Z., Altunayoglu V. Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in patients with relapsing-remitting multiple sclerosis treated with interferon beta. Clin. Neurol. Neurosurg. 2006, 108:124-128.
4. + T Cells in MS. Eur. J. Immunol. 2009, 39:2525-2536.
5. + regulatory T-cell function: an ex vivo and in vitro longitudinal study in relapsing-remitting multiple sclerosis. J. Neuroimmunol. 2007, 182:204-211.
6. Guo B., Chang E.Y., Cheng G. The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice. J. Clin. Invest. 2008, 118:1680-1690.
7. +CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. Eur. J. Immunol. 2005, 35:3343-3352.
8. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061.
9. Huan J., Culbertson N., Spencer L., Bartholomew R., Burrows G.G., Chou Y.K., Bourdette D., Ziegler S.F., Offner H., Vandenbark A.A. Decreased FOXP3 levels in multiple sclerosis patients. J. Neurosci. Res. 2005, 81:45-52.
10. Kim J.I., Sonawane S.B., Lee M.K., Lee S.H., Duff P.E., Moore D.J., O'Connor M.R., Lian M.M., Deng S., Choi Y., Yeh H., Caton A.J., Markmann J.F. Blockade of GITR-GITRL interaction maintains Treg function to prolong allograft survival. Eur. J. Immunol. 2010, 40:1369-1374.
11. Korporal M., Haas J., Balint B., Fritzsching B., Schwarz A., Moeller S., Fritz B., Suri-Payer E., Wildemann B. Interferon beta-induced restoration of regulatory T-cell function in multiple sclerosis is prompted by an increase in newly generated naive regulatory T cells. Arch. Neurol. 2008, 65:1434-1439.
12. Kozovska M.E., Hong J., Zang Y.C., Li S., Rivera V.M., Killian J.M., Zhang J.Z. ZInterferon beta induces T-helper 2 immune deviation in MS. Neurology 1999, 53:1692-1697.
13. Namdar A., Nikbin B., Ghabaee M., Bayati A., Izad M. Effect of IFN-beta therapy on the frequency and function of CD4(+)CD25(+) regulatory T cells and Foxp3 gene expression in relapsing-remitting multiple sclerosis (RRMS): a preliminary study. J. Neuroimmunol. 2010, 218:120-124.
14. Nocentini G., Riccardi C. GITR: a multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily. Eur. J. Immunol. 2005, 35:1016-1022.
15. Nocentini G., Ronchetti S., Cuzzocrea S., Riccardi C. GITR/GITRL: more than an effector T cell co-stimulatory system. Eur. J. Immunol. 2007, 37:1165-1169.
16. Prinz M., Schmidt H., Mildner A., Knobeloch K.P., Hanisch U.K., Raasch J., Merkler D., Detje C., Gutcher I., Mages J., Lang R., Martin R., Gold R., Becher B., Bruck W., Kalinke U. Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system. Immunity 2008, 28:675-686.
17. Read S., Malmstrom V., Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J. Exp. Med. 2000, 192:295-302.
18. Ronchetti S., Zollo O., Bruscoli S., Agostini M., Bianchini R., Nocentini G., Ayroldi E., Riccardi C. GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations. Eur. J. Immunol. 2004, 34:613-622.
19. Shevach E.M., Stephens G.L. The GITR-GITRL interaction: co-stimulation or contrasuppression of regulatory activity? Nature reviews. Immunology 2006, 6:613-618.
20. Shinohara M.L., Kim J.H., Garcia V.A., Cantor H. Engagement of the type I interferon receptor on dendritic cells inhibits T helper 17 cell development: role of intracellular osteopontin. Immunity 2008, 29:68-78.
21. Sonawane S.B., Kim J.I., Lee M.K., Lee S.H., Duff P.E., Moore D.J., Lian M.M., Deng S., Choi Y., Yeh H., Caton A.J., Markmann J.F. GITR blockade facilitates Treg mediated allograft survival. Transplantation 2009, 88:1169-1177.
22. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 1998, 10:1969-1980.
23. + T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J. Exp. Med. 2004, 199:1467-1477.
24. + regulatory T cells restore normoglycemia in diabetic NOD mice. J. Exp. Med. 2007, 204:191-201.
25. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 1998, 188:287-296.
26. + immunoregulatory T cells is antigen nonspecific. J. Immunol. 2000, 164:183-190.
27. + regulatory T-cell function and FOXP3 expression. J. Neurosci. Res. 2006, 83:1432-1446.
28. + regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 2004, 199:971-979.
29. + regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 2003, 198:235-247.
30. Yushchenko M., Mader M., Elitok E., Bitsch A., Dressel A., Tumani H., Bogumil T., Kitze B., Poser S., Weber F. Interferon-beta-1 b decreased matrix metalloproteinase-9 serum levels in primary progressive multiple sclerosis. J. Neurol. 2003, 250:1224-1228.